These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 29174131
21. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial. Legouté F, Bensadoun RJ, Seegers V, Pointreau Y, Caron D, Lang P, Prévost A, Martin L, Schick U, Morvant B, Capitain O, Calais G, Jadaud E. Radiat Oncol; 2019 May 22; 14(1):83. PubMed ID: 31118057 [Abstract] [Full Text] [Related]
24. IMRT with simultaneous integrated boost and concurrent chemotherapy for nasopharyngeal cancer: plan evaluation and treatment outcome. Kim JW, Cho JH, Keum KC, Kim JH, Kim GE, Lee JY, Kim SK, Lee CG. Jpn J Clin Oncol; 2012 Dec 22; 42(12):1152-60. PubMed ID: 23077243 [Abstract] [Full Text] [Related]
25. Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy. Sher DJ, Thotakura V, Balboni TA, Norris CM, Haddad RI, Posner MR, Lorch J, Goguen LA, Annino DJ, Tishler RB. Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e215-22. PubMed ID: 21531515 [Abstract] [Full Text] [Related]
26. Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) with other antioxidants. Osaki T, Ueta E, Yoneda K, Hirota J, Yamamoto T. Head Neck; 1994 Nov 15; 16(4):331-9. PubMed ID: 8056578 [Abstract] [Full Text] [Related]
32. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck. Inohara H, Takenaka Y, Yoshii T, Nakahara S, Yamamoto Y, Tomiyama Y, Seo Y, Isohashi F, Suzuki O, Yoshioka Y, Sumida I, Ogawa K. Int J Radiat Oncol Biol Phys; 2015 Apr 01; 91(5):934-41. PubMed ID: 25832686 [Abstract] [Full Text] [Related]
38. Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study. Czito BG, Deming DA, Jameson GS, Mulcahy MF, Vaghefi H, Dudley MW, Holen KD, DeLuca A, Mittapalli RK, Munasinghe W, He L, Zalcberg JR, Ngan SY, Komarnitsky P, Michael M. Lancet Gastroenterol Hepatol; 2017 Jun 01; 2(6):418-426. PubMed ID: 28497757 [Abstract] [Full Text] [Related]